Descriptive illustration of ArcDFI.

Descriptive illustration of ArcDFI.

<p><b>a)</b> Model architecture for ArcDFI. The parameters in Compound Substructure Encoder, Compound Graph Encoder and Compound-CYP Interaction Block are shared by both drug and food compounds. <b>b)</b> Detailed illustration of the Compound-CYP interaction block. <...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autore principale:	Mogan Gim (22439477) (author)
Altri autori:	Jaewoo Kang (239124) (author), Donghyeon Park (11432730) (author), Minji Jeon (765687) (author)
Pubblicazione:	2025
Soggetti:	Biochemistry Medicine Molecular Biology Pharmacology Ecology Virology Environmental Sciences not elsewhere classified Biological Sciences not elsewhere classified Information Systems not elsewhere classified handling compounds unseen attention regularization guided improved predictive generalizability div >< p incorporating cyp450 interactions cyp450 interactions limited generalizability food interactions cyp450 isoenzymes predicting dfis dfi predictions dfi ). deeply involved current understanding
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Overview of ArcDFI.
di: Mogan Gim (22439477)
Pubblicazione: (2025)

Analysis on ArcDFI’s Compound-CYP Interaction Block for drug-food compound pair Midazolam and Berberine.
di: Mogan Gim (22439477)
Pubblicazione: (2025)

Analysis on ArcDFI’s Compound-CYP Interaction Block for drug-food compound pair Sulfonylurea and Salicylate.
di: Mogan Gim (22439477)
Pubblicazione: (2025)

Detailed statistics for each dataset where our newly constructed ArcDFI dataset is an integration of FooDrugs and FDMine.
di: Mogan Gim (22439477)
Pubblicazione: (2025)

Evaluation results for ArcDFI, its ablated version and baseline models under the cold food experiment setting. All evaluation scores were averaged over three iterations along with their standard deviation. Best results are bold-faced.
di: Mogan Gim (22439477)
Pubblicazione: (2025)

Evaluation results for ArcDFI, its ablated version, and baseline models under the cold drug experiment setting. All evaluation scores were averaged over three iterations along with their standard deviation. Best results are bold-faced.
di: Mogan Gim (22439477)
Pubblicazione: (2025)

Detailed illustration for Attention Regularization Auxiliary Loss Objective.
di: Mogan Gim (22439477)
Pubblicazione: (2025)

pcbi.1013055.t005 -
di: Mogan Gim (22439477)
Pubblicazione: (2025)

Number of drug compounds annotated with each type of CYP450 isoenyzme (1A2, 3A4, 2C19, 2C9, 2D6) interaction (substrate, inhibition) label.
di: Mogan Gim (22439477)
Pubblicazione: (2025)

Table 9_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Table 10_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Table 7_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Table 8_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Table 6_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Table 3_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Table 4_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Table 5_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Table 1_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Table 2_Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence.xlsx
di: Wan-Jung Cheng (220322)
Pubblicazione: (2025)

Data Sheet 1_The CYP303A1 is essential in embryonic development of Nilaparvata lugens Stål (Hemiptera: delphacidae).docx
di: Yingzhen Liu (7424057)
Pubblicazione: (2025)

Mechanical Insights of MSBP1 in Regulating Cytochrome P450 Enzymes through Monitoring Intracellular Calcium
di: Yangyi Liu (6889742)
Pubblicazione: (2025)

Table 1_Potential induction of the relative mRNA expression levels of CYP450 by Zhicaowu-Hezi (Aconiti kusnezoffii radix preparata and Terminalia chebula Retz.).docx
di: Junxuan Zhu (15138585)
Pubblicazione: (2025)

Detailed description of the RNA samples used for RNA seq.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Detailed description of the PCR products intended for Deep Amplicon Sequencing with the DNA concentration measured after PCR and the sample origin.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

research data of EmFi , DeFi and digital financial inclusion.xlsx
di: Mustafa h. (21976997)
Pubblicazione: (2025)

Discovery of Metabolic Cross-Coupling in Phenol-Arylamine Mixtures by Cytochrome P450 via Combined Computational and Experimental Approaches
di: Shiyang Cheng (1422679)
Pubblicazione: (2025)

Discovery of Metabolic Cross-Coupling in Phenol-Arylamine Mixtures by Cytochrome P450 via Combined Computational and Experimental Approaches
di: Shiyang Cheng (1422679)
Pubblicazione: (2025)

Genome annotation metrics for <i>P. ovis</i> used in RNASeq and population genomic analyses.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Genome assembly metrics for sheep- and cattle-derived <i>P. ovis</i> assemblies.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Overview of highlighted differentially expressed genes for each comparison.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Summary of the cysLGIC encoding genes in <i>P. ovis</i> with the corresponding cysLGICs with the highest homology in <i>T. urticae</i>, <i>D. melanogaster</i>, <i>S. scabiei</i>, <i>D. pteronyssinus</i> and <i>R. microplus.</i>
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Overview of the different samples used for DNA extraction together with the number of mites, region of origin, <i>in vivo</i> ML susceptibility and host species as established by [13].
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Per gene absolute mean difference in F<sub>st</sub> (which we term |F<sub>st</sub>|) between all Resistant and Suspected Resistant versus Susceptible comparisons and Resistant and Suspected Resistant versus Resistant and Suspected Resistant comparisons.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Copy number variation of the over-expressed UGT (PsoOvis1B004414 and PsoOvis1B010992) and CYP genes (PsoOvis1B011549).
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Relatedness of genome re-sequenced <i>P. ovis</i> populations.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Rmcorr correlation analysis between log<sub>2</sub> real-time quantitative PCR and RNASeq expression values for six selected genes.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Summary of RNASeq results.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

A maximum likelihood phylogenetic tree of cysLGIC subunits from <i>P. ovis</i> (PSOVI), <i>T. urticae</i> (Tu), <i>D. melanogaster</i> (Dm), <i>S. scabiei</i> (Ss) and <i>D. pteronyssinus</i> (XP_).
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Heatmap of the transcription levels (expressed in reads per millon) of the different <i>P. ovis</i> cysLGIC subunit encoding genes.
di: Jack Hearn (3243372)
Pubblicazione: (2025)

Exposed ML-resistant (RES<sub>exposed</sub>) versus unexposed (RES<sub>unexposed</sub>) ML-resistant <i>P. ovis</i> Sleuth results for all isoforms of all genes.
di: Jack Hearn (3243372)
Pubblicazione: (2025)